Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
35 Cards in this Set
- Front
- Back
electrical properties of the heart
|
-SA node: pacemaker for the heart
-AV node: impulses originating in atria must travel through AV node to reach ventricles -His-Purkinje fibers: conduct electrical excitation very rapidly to all parts of ventricles |
|
cardiac action potentials
|
-cardiac cells initiate and conduct conduct action potentials consisting of self-propagating waves of depolarization followed by repolarization
-generated by movement of ions into and out of cells -ion fluxes happen through specific channels in the cell membrane |
|
fast potential locations
|
occur in His-Purkinje fibers and in atrial and ventricular muscles
|
|
fast potential phases
|
0) depolarization
1) (partial) repolarization 2) plateau 3) repolarization 4) stable potential |
|
slow potential locations
|
occur in cells of SA and AV nodes
|
|
slow potential phases
|
0) slow depolarization mediated by calcium influx
1) absent 2 and 3) not significant 4) depolarization |
|
atrial fibrillation
|
-supraventricular
-most common sustained dysrhythmia -treated with beta blockers (e.g. atenolol or metoprolol) -treated with warfarin for stroke patients |
|
atrial flutter
|
-supraventricular
-250-300 bpm -treatment: cardioversion |
|
sustained supraventricular tachycardia
|
-supraventricular
-150-200 bpm -first line of treatment is carotid sinus massage or Valsalva's maneuver -second line of treatment is IV beta blocker or calcium channel blocker |
|
sustained ventricular tachycardia
|
-dangerous
-150-200 bpm -treatment: cardioversion or IV amiodarone |
|
ventricular fibrillation
|
-life-threatening emergency
-treatment: defibrillation |
|
ventricular premature contractions/beats
(VPCs or VPBs) |
-beats occur prematurely in cardiac cycle
-treated with beta blocker |
|
digoxin-induced ventricular dysrhythmias
|
-treatment: lidocaine or phenytoin
-can almost always be controlled |
|
torsades de pointes
|
-ventricular dysrhythmia
-atypical, undulating, rapid, ventricular tachydysrhythmia that can evolve into vfib -treatment: IV magnesium plus cardioversion |
|
classes of antidysrhythmics
|
I: sodium channel blockers
II: beta blockers III: potassium channel blockers IV: calcium channel blockers |
|
indications and therapeutic effects of QUINIDINE (class IA)
|
indications: supraventricular and ventricular dysrhythmias
effects on heart: -blocks sodium channels -slows impulse conduction -delays repolarization -blocks vagal input to the heart -widens QRS complex -prolongs QT interval |
|
side effects of QUINIDINE
|
(class IA)
-diarrhea -cinchonism -cardiotoxicity -arterial embolism -alpha-adrenergic blockade resulting in hypotension -hypersensitivity reactions |
|
drug interactions of QUINIDINE
|
(class IA)
-digoxin |
|
therapeutic effects of LIDOCAINE (class IB)
|
-blocks sodium channel
-slows conduction in all areas of the heart -reduces automaticity of ventricles and His-Purkinje system -accelerates repolarization other class IB agents: phenytoin and mexiletine |
|
side effects of LIDOCAINE
|
(class IB)
-CNS effects -paresthesias -drowsiness -confusion |
|
flecainide and propafenone (class IC)
|
-block cardiac sodium channels
-delay ventricular repolarization -can exacerbate existing dysrhythmias and create new ones |
|
major components of an ECG
|
-P wave: atrial depolarization
-QRS complex: ventricular depolarization -T wave: ventricular repolarization |
|
PROPANOLOL (Inderal)
|
-non-selective beta-adrenergic antagonist
-class II -decreased automaticity of SA node -decreased conduction velocity through AV node -decreased myocardial contractility |
|
PROPANOLOL (Inderal) indications and therapeutic effects
|
(class II)
-dysrhythmias caused by excessive sympathetic stimulation -supraventricular tachydysrhythmias -suppression of excessive discharge -slowing of ventricular rate |
|
adverse effects of PROPANOLOL (Inderal)
|
-heart block
-heart failure -AV block -sinus arrest -hypotension -bronchospasm in asthma patients |
|
BRETYLIUM (class III) indications and therapeutic effects
|
indications:
-vfib -vtach therapeutic effects: -delay repolarization of fast potentials -prolonged QT interval |
|
BRETYLIUM side effects
|
(class III)
-profound persistent hypertension |
|
AMIODARONE (Cordarone, Pacerone) (class III) indications
|
-for life-threatening ventricular dysrhythmias only
-recurrent vfib -recurrent hemodynamically unstable vtach |
|
AMIODARONE (Cordarone, Pacerone)
therapeutic effects |
(class III)
-reduces automaticity in SA node -negative inotropic -reduces conduction velocity -QRS widening -prolonged PR and QT intervals |
|
AMIODARONE (Cordarone, Pacerone) side effects
|
(class III)
-pulmonary toxicity -cardiotoxicity -toxicity in pregnancy and breastfeeding -corneal microdeposits -optic neuropathy |
|
AMIODARONE (Cordarone, Pacerone) drug interactions
|
-quinidine
-digoxin -procainamide -diltiazem -phenytoin -warfarin |
|
VERAPAMIL and DILTIAZEM (class IV) indications and therapeutic effects
|
indications: slow ventricular rate due to afib or atrial flutter, termination of SVT
therapeutic effects: -reduces SA node automaticity -slows AV node conduction -negative inotropic |
|
VERAPAMIL and DILTIAZEM adverse effects
|
(class IV)
-bradycardia -hypotension -AV block -heart failure -peripheral edema -constipation |
|
ADENOSINE indications and therapeutic effects
|
indication: paroxysmal SVT (supraventricular tachycardia)
therapeutic effects: -decreases SA node automaticity -slows conduction through AV node -prolonged PR interval |
|
ADENOSINE side effects and drug interactions
|
side effects:
-sinus bradycardia -dyspnea -hypotension -FACIAL FLUSHING drug interactions: -methylxanthines -dipyridamole |